BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30820801)

  • 1. Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection.
    Prakash LR; Wang H; Zhao J; Nogueras-Gonzalez GM; Cloyd JM; Tzeng CD; Kim MP; Lee JE; Katz MHG
    J Gastrointest Surg; 2020 Feb; 24(2):368-379. PubMed ID: 30820801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
    Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.
    Han SS; Park SJ; Kim SH; Cho SY; Kim YK; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK
    Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection.
    Mierke F; Hempel S; Distler M; Aust DE; Saeger HD; Weitz J; Welsch T
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):730-736. PubMed ID: 27554501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.
    Han S; Choi DW; Choi SH; Heo JS; Han IW; You YH
    Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients.
    Ramacciato G; Nigri G; Petrucciani N; Pinna AD; Ravaioli M; Jovine E; Minni F; Grazi GL; Chirletti P; Tisone G; Napoli N; Boggi U
    Ann Surg Oncol; 2016 Jun; 23(6):2028-37. PubMed ID: 26893222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection of the Portal-Superior Mesenteric Vein in Pancreatic Cancer: Pathological Assessment and Recurrence Patterns.
    Groen JV; van Manen L; van Roessel S; van Dam JL; Bonsing BA; Doukas M; van Eijck CHJ; Farina Sarasqueta A; Putter H; Vahrmeijer AL; Verheij J; Besselink MG; Groot Koerkamp B; Mieog JSD
    Pancreas; 2021 Sep; 50(8):1218-1229. PubMed ID: 34714287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic adenocarcinoma: A simple CT score for predicting margin-positive resection in patients with resectable disease.
    Cassinotto C; Dohan A; Zogopoulos G; Chiche L; Laurent C; Sa-Cunha A; Cuggia A; Reinhold C; Gallix B
    Eur J Radiol; 2017 Oct; 95():33-38. PubMed ID: 28987689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
    Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
    ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
    Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
    Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma.
    Roch AM; House MG; Cioffi J; Ceppa EP; Zyromski NJ; Nakeeb A; Schmidt CM
    J Gastrointest Surg; 2016 Mar; 20(3):479-87; discussion 487. PubMed ID: 26768008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration.
    Malleo G; Maggino L; Marchegiani G; Feriani G; Esposito A; Landoni L; Casetti L; Paiella S; Baggio E; Lipari G; Capelli P; Scarpa A; Bassi C; Salvia R
    Pancreatology; 2017; 17(5):847-857. PubMed ID: 28843714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining venous involvement in borderline resectable pancreatic cancer.
    Chun YS; Milestone BN; Watson JC; Cohen SJ; Burtness B; Engstrom PF; Haluszka O; Tokar JL; Hall MJ; Denlinger CS; Astsaturov I; Hoffman JP
    Ann Surg Oncol; 2010 Nov; 17(11):2832-8. PubMed ID: 20725860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is pancreatectomy with resection of the retro-pancreatic vessels for cancer justified?].
    Baulieux J; Adham M; Oussoultzoglou E; De la Roche E; Berthoux N; Bourdeix O; Ducerf C
    Chirurgie; 1998 Nov; 123(5):438-44. PubMed ID: 9882911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.
    Wang J; Estrella JS; Peng L; Rashid A; Varadhachary GR; Wang H; Lee JE; Pisters PW; Vauthey JN; Katz MH; Gomez HF; Evans DB; Abbruzzese JL; Fleming JB; Wang H
    Cancer; 2012 Aug; 118(15):3801-11. PubMed ID: 22180096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical Outcomes of Pancreatectomy with Resection of the Portal Vein and/or Superior Mesenteric Vein and Jejunal Vein for Pancreatic Head Cancer: A Multicenter Study.
    Nagakawa Y; Jang JY; Kawai M; Kim SC; Inoue Y; Matsuyama R; Heo JS; Honda M; Sugiura T; Ohtsuka M; Mizuno S; Kwon W; Uemura K; Han HS; Sugimoto M; Okano K; Nakamura M; Wada K; Kumamoto Y; Osakae H; Tsuchida A; Yoon YS; Park JS; Yamaue H; Endo I
    Ann Surg; 2023 May; 277(5):e1081-e1088. PubMed ID: 34913900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of resections for pancreatic adenocarcinoma with suspected venous involvement: a single center experience.
    Michalski CW; Kong B; Jäger C; Kloe S; Beier B; Braren R; Esposito I; Erkan M; Friess H; Kleeff J
    BMC Surg; 2015 Aug; 15():100. PubMed ID: 26296752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic neck cancer has specific and oncologic characteristics regarding portal vein invasion and lymph node metastasis.
    Hirono S; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yamaue H
    Surgery; 2016 Feb; 159(2):426-40. PubMed ID: 26253244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens.
    Delpero JR; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Autret A; Turrini O; Monges-Ranchin G; Boher JM
    HPB (Oxford); 2014 Jan; 16(1):20-33. PubMed ID: 23464850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resection of portal and/or superior mesenteric vein and reconstruction by using allogeneic vein for pT3 pancreatic cancer.
    Zhang XM; Fan H; Kou JT; Zhang XX; Li P; Dai Y; He Q
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1498-503. PubMed ID: 26825612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.